ResearchMoz

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Research In China
Published Date » 2013-11-29
No. Of Pages » 65

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese preparations have grown year by year. In 2006-2012, China’s injection output presented the CAGR of 19.2%. However, due to the low barriers to entry, China has seen some signs of the surplus injection capacity, which exceeds the demand by roughly 40%.

Overcapacity and fierce competition are caused by the irrational injection product structure and homogeneity. For example, the output and sales volume of fluid balance injection products with low added value account for 89% of the injection market, but the sales revenue only shares 47%. At the same time, the market demand for amino acids, fat emulsion dual-chamber bags, fat emulsion, total parenteral nutrition, hydroxyethyl starch and unique traditional Chinese medicine injection is quite strong.

Compared to Europe and other developed countries, the concentration degree of Chinese LVP market is still lower. At present, 200 ones of 400 qualified Chinese LVP enterprises run business soundly. By output, the top 10 Chinese companies contribute about 65%; in terms of sales revenue, they devote about 40 %.

Like other chemical preparation segments, Chinese high-end LVP market is still dominated by foreign pharmaceutical companies such as Japan Otsuka, Germany Fresenius Kabi, and USA Baxter.

Take fat emulsion products for example. Fat emulsion is imported by China frequently as a blood and hematopoietic system drug in recent years, with its import volume having been at the high level of typical urban hospitals in 22 Chinese cities for consecutive years. Particularly, the procurement value of moderate and long-chain fat emulsion imported by Chinese typical hospitals hit RMB354million. In China, fat emulsion injection suppliers include Kelun Pharma, Sino-Swed Pharmaceutical Corp, Ltd. (under Fresenius Kabi) and Guangzhou Baxter Qiaoguang (under Baxter) with the respective output of 14.19 million bottles/bags, 8.1 million bottles / bags (including medium/long-chain fat emulsion) and 5.69 million bottles/bags (medium/long-chain fat emulsion) in 2012.

The report highlights the followings:

  • Status quo, competition patterns, product structure, regional distribution and development forecast of Chinese LVP market;
  • Status quo and competition patterns of fluid balance injection, therapeutic injection, nutrition injection, injection for blood volume expansion and peritoneal dialysis fluid injection and other market segments;
  • Operation, LVP business and prospects of 10 companies including Kelun Pharma, China Resources Double-Crane, Fengyuan Pharmaceutical, Huaren Pharmaceutical, Southwest Pharmaceutical and Lijun International Pharmaceutical. 
TABLE OF CONTENT

1 Overview of LVP
1.1 Definition and Classification
1.2 Industry Chain

2 Overview of China LVP Industry Development
2.1 Status Quo
2.2 Competition Pattern
2.3 Product Structure
2.4 Regional Distribution
2. 5 Development Forecast 

3 Chinese LVP Market Segments
3.1 Injection for Fluid Balance
3.2 Therapeutic Injection
3.3 Nutritious Injection
3.3.1 Fructose Injection
3.3.2 Amino Acid Injection
3.3.3 Fat Emulsion Injection
3.4 Injection for Blood Volume Expansion 
3.4.1 Dextran Injection
3.4.2 Hydroxyethyl Starch Injection
3.5 Peritoneal Dialysis Solution

4 Main Companies
4.1 Kelun Pharma 
4.1.1 Profile 
4.1.2 Operation 
4.1.3 Revenue Structure 
4.1.4 Gross Margin 
4.1.5 Clients and Suppliers 
4.1.6 R & D and Investment
4.1.7 LVP Business 
4.1.8 Development Forecast 
4.2 China Resources Double-Crane 
4.2.1 Profile 
4.2.2 Operation 
4.2.3 Revenue Structure 
4.2.4 Gross Margin 
4.2.5 Major Clients 
4.2.6 LVP Business 
4.2.7 Development Forecast 
4.3 Fengyuan Pharmaceutical  
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Revenue Structure 
4.3.4 Gross Margin 
4.3.5 Clients and Suppliers 
4.3.6 LVP Business 
4.3.7 Development Forecast 
4.4 Huaren Pharmaceutical
4.4.1 Profile 
4.4.2 Operation 
4.4.3 Revenue Structure 
4.4.4 Gross Margin 
4.4.5 Clients and Suppliers 
4.4.6 R & D and Investment
4.4.7 Development Forecast 
4.5 Southwest Pharmaceutical 
4.5.1 Profile 
4.5.2 Operation 
4.5.3 Revenue Structure 
4.5.4 Gross Margin 
4.5.5 Major Clients 
4.5.6 LVP Business 
4.5.7 Development Forecast 
4.6 Lijun International Pharmaceutical (Holding)
4.6.1 Profile
4.6.2 Operation 
4.6.3 Shijiazhuang No.4 Pharmaceutical 
4.7 Other Companies
4.7.1 Qingzhou Yaowang Medicine 
4.7.2 Jilin Dubang Pharmaceutical 
4.7.3 Shandong Lukang Cisen Pharmaceutical  
4.7.4 China Otsuka Pharmaceutical 

List of Tables

NA

List of Figures

NA

Upcoming Reports:

E-Clinical Trial Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
E-clinical trial solutions are a combination of technology, products and services that work together to automate and manage clinical trials. This term is used to refer to electronic systems that are used for conducting or automating the management of clinical trials and minimizing human errors.Conducting clinical trials for a novel drug requires efficient management of large amount of essential data with real-time analysis.Such management solutions improve efficiency, enhance the speed of clinical trials process, reduce clinical trial costs, and enable better data management...
Natural Antioxidants - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Natural antioxidants are mostly found in fresh food. They have the ability to remove harmful/toxic substances from body. They are chemically free radicals and stable in their own way and hence do not give away electrons. Antioxidants convert harmful toxins into harmless products which are excreted from body as waste products. They prevent the body from oxidation which produces free radicals and damages cells. Foods which are rich in natural antioxidants helps prevent cancer and also act as anti-aging agents. They also reduces risk of heart disease by significantly absorbing bad...
Fast Food Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Fast foods are food products that can be prepared and served within a short stipulated amount of time. It includes various types of edible snacks such as burgers, pizzas, fries and rolls among others. The raw materials needed for this market mainly constitute of flour, vegetables and meat. Several companies produce their own raw material to bring the supplier power under their control which is one form of backward integration. Fast foods are mainly found in restaurants and street vendors. Rise in disposable income of middle class consumers and the demand for quick bites in...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...